Researchers from the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) are playing leading roles in a major new UK-wide research consortium aiming to improve treatment and outcomes for people living with osteoarthritis.
Researchers from the Ineos Oxford Institute for antimicrobial research (IOI) have identified a new class of molecule that could help protect \u2018last-resort\u2019 antibiotics from bacterial resistance, and reduce the amount of antibiotics needed to treat infections by up to 32 times.
A major international study led by researchers at the Kennedy Institute of Rheumatology at the University of Oxford has found that osteoarthritis (OA) \u2013 the most common form of arthritis worldwide \u2013 is not a collection of separate diseases, as many scientists had previously speculated, but rather a single condition with common core underlying biological pathways.
A new study from the University of Oxford and le Centre National de la Recherche Scientifique (CNRS) has shown that the brain uses rhythms for brain cell impulses to coordinate activity across memory-related regions in the brain during learning and help reactivate those experiences afterwards, strengthening what we remember.
The Coalition for Epidemic Preparedness Innovations (CEPI) has announced today that it will urgently accelerate the development of three investigational vaccines targeting the Bundibugyo ebolavirus that has caused a rapidly spreading epidemic in the Democratic Republic of the Congo (DRC) and neighbouring Uganda, including one being developed by the Oxford Vaccine Group at the University of Oxford.
A new partnership will unite expertise, infrastructure and data across borders to accelerate diagnosis, treatment and ultimately prevention of major diseases \u2013 starting with women\u2019s health, infectious diseases and pandemic preparedness.
The Department of Paediatrics at the University of Oxford today announces the launch of Genes, Brains, and Breakthroughs, a new educational campaign designed to raise public awareness and understanding of neurodevelopmental disorders through a series of accessible, family-informed video resources.
Researchers have discovered that some human blood stem cells retain a lasting \u201cmemory\u201d of inflammation, a finding that could help explain links between ageing, chronic disease, and blood cancers
Twelve renowned Oxford researchers have been elected Fellows of the Royal Society, the UK\u2019s national academy of sciences, in recognition of their exceptional contributions to advancing scientific knowledge.
The Infectious Diseases Data Observatory (IDDO) has been awarded the CoreTrustSeal, an internationally recognised certification for trustworthy data repositories.
The University Oxford has received \u00a31.17m of funding from Baszucki Group to assess the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P).
New technology could help identify fetal complications earlier in high-risk pregnancies. Researchers at the University of Oxford and collaborators have helped develop a wearable ultrasound patch capable of continuously monitoring fetal wellbeing during pregnancy, offering a potential new approach to identifying complications earlier in high-risk pregnancies.
Matthew Wood, Professor of Neuroscience in the Department of Paediatrics at the University of Oxford and Director & Chief Scientific Officer of the Oxford-Harrington Rare Disease Centre, comments on new government plans to bring treatments for rare diseases a step closer.
Proximity to unsafe water strongly predicts schistosomiasis exposure, explaining sharp differences in infection and re\u2011infection across communities.
In response to the current Bundibugyo Ebolavirus outbreak in the Democratic Republic of the Congo, the Oxford Vaccine Group (OVG) is working urgently with Oxford\u2019s own Clinical BioManufacturing Facility and the Serum Institute of India Pvt. Ltd. (SIIPL), to rapidly produce and scale doses of our ChAdOx-based monovalent Bundibugyo Ebolavirus candidate vaccine, ChAdOx1 BDBV.
Ahead of the forecast high temperatures over the UK\u2019s Spring Bank Holiday weekend, Dr Laurence Wainwright, Senior Departmental Lecturer at the Smith School of Enterprise & Environment and Senior Researcher in the Department of Psychiatry, outlines the unexpected risks.
Engineers and healthcare scientists from the University of Oxford and the University of Cape Town, South Africa, have come together to improve technologies for diagnosing disease and furthering our understanding of fundamental processes of disease. By advancing three-dimensional imaging of tissue at the microscopic scale, tissue-based analysis of changes in gene expression, and artificial intelligence methodologies, the team aims to generate new insights from tissue samples into health and disease.
Following the outbreak of Andes hantavirus disease on the cruise ship MV Hondius, UK universities and the UK Health Security Agency (UKHSA) have launched a new clinical study to characterise infection and disease associated with Andes hantavirus.
![\"Woman](\"https://www.medsci.ox.ac.uk/news/pioneering-study-sets-out-to-answer-why-osteoarthritis-impacts-patients-differently/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n